CTNM
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ: CTNM · HEALTHCARE · BIOTECHNOLOGY
$12.82
+6.48% today
Updated 2026-04-30
Market cap
$463.34M
P/E ratio
—
P/S ratio
11.15x
EPS (TTM)
$-2.17
Dividend yield
—
52W range
$3 – $16
Volume
0.3M
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-26.10%
ROA
-17.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $0.00 | $-29.00M | — | — | — |
| 2022 | $0.00 | $-24.25M | — | — | — |
| 2023 | $50.00M | $22.72M | 100.00% | -32.15% | 45.44% |
| 2024 | $0.00 | $-42.26M | — | — | — |
| 2025 | $0.00 | $-59.98M | — | — | — |